Adoption allows ICON to take full advantage of the Medidata "Data Experience," leveraging AI to unify data sources, standardize outputs, and reduce reconciliation efforts NEW YORK, March 20, ...

Clinical research organisation (CRO) ICON has begun the integration of Medidata Clinical Data Studio into its clinical studies. This development makes ICON the first CRO to completely integrate this ...

BERWYN, PENNSYLVANIA and DUBLIN, IRELAND, 4 March 2025 - Mural Health Technologies, Inc., a patient-first clinical trial technology company, and ICON plc (NASDAQ: ICLR), a global healthcare ...

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation (CRO), finishes the second half of 2023 with positive recognition as a ...

LEO Pharma has partnered with clinical research organisation ICON to advance trial execution within medical dermatology. LEO said the deal will enable it to scale up its clinical trial operations in a ...